Insights

Expanding Manufacturing Capacity Jellatech is actively scaling its production capabilities with new 9,000-square-foot facilities in North Carolina, creating opportunities to supply large-volume orders across the biomedical, food, cosmetic, and pet food industries.

Innovative Product Development The company's focus on developing human and mammalian collagen through cellular agriculture positions it to meet the rising demand for animal-free, ethically produced proteins in healthcare, food, and skincare markets.

Funding and Growth With a recent seed funding round of $3.5 million, Jellatech has the financial backing to accelerate research and commercial scale-up, opening avenues for strategic partnerships and early adopter integrations.

Market Expansion Potential The company's unique ability to provide fully functional, bio-identical human collagen targets a vast and emerging $100-150 billion market, presenting opportunities to offer differentiated products for regenerative medicine, aesthetics, and therapeutics.

Partnership and Collaboration Opportunities Jellatech's collaborations with companies in pet food, cosmetics, and biomedical research indicate a proactive approach to diversifying application areas, which sales teams can leverage by connecting with multiple verticals seeking animal-free, sustainable protein solutions.

Jellatech Tech Stack

Jellatech uses 8 technology products and services including Fastly, WordPress, MySQL, and more. Explore Jellatech's tech stack below.

  • Fastly
    Content Delivery Network
  • WordPress
    Content Management System
  • MySQL
    Database
  • Google Workspace
    Email
  • Google Cloud
    Infrastructure As A Service
  • React
    Javascript Frameworks
  • Polyfill
    Javascript Libraries
  • Bootstrap
    UI Frameworks

Media & News

Jellatech's Email Address Formats

Jellatech uses at least 1 format(s):
Jellatech Email FormatsExamplePercentage
First.Last@jellatech.comJohn.Doe@jellatech.com
50%
First.Last@jellatech.comJohn.Doe@jellatech.com
50%

Frequently Asked Questions

What is Jellatech's official website and social media links?

Minus sign iconPlus sign icon
Jellatech's official website is jellatech.com and has social profiles on LinkedInCrunchbase.

What is Jellatech's SIC code NAICS code?

Minus sign iconPlus sign icon
Jellatech's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Jellatech have currently?

Minus sign iconPlus sign icon
As of December 2025, Jellatech has approximately 10 employees across 1 continents, including North America. Key team members include Head Of Science: C. G.Founder & Ceo: S. M.Member Board Of Directors: P. A.. Explore Jellatech's employee directory with LeadIQ.

What industry does Jellatech belong to?

Minus sign iconPlus sign icon
Jellatech operates in the Biotechnology Research industry.

What technology does Jellatech use?

Minus sign iconPlus sign icon
Jellatech's tech stack includes FastlyWordPressMySQLGoogle WorkspaceGoogle CloudReactPolyfillBootstrap.

What is Jellatech's email format?

Minus sign iconPlus sign icon
Jellatech's email format typically follows the pattern of First.Last@jellatech.com. Find more Jellatech email formats with LeadIQ.

How much funding has Jellatech raised to date?

Minus sign iconPlus sign icon
As of December 2025, Jellatech has raised $3.5M in funding. The last funding round occurred on Sep 06, 2023 for $3.5M.

Jellatech

Biotechnology ResearchNorth Carolina, United States2-10 Employees

Jellatech is a B2B biotech business based in Raleigh, NC producing human proteins for advancements in health using our unique cell-based technology. By unlocking the production of complex proteins at scale, Jellatech is enabling the creation of new possibilities for health and longevity, starting with Type I collagen.

Jellatech’s mission is to revolutionize biomedical applications through cutting-edge, human-identical proteins. Jellatech enables advancements in tissue regeneration, injectable aesthetics, cell and gene therapy, and various therapeutic applications by supplying human-identical collagen and complex proteins.

With all of it's known limitations, the tissue-extracted bovine and porcine medical grade collagen market for biomedical applications is expected to surpass $2.4B by 2032; however, with the introduction of a viable supply of human collagen across key verticals, the total addressable market (TAM) for human collagen alone could surpass $100-150 billion in the near future.

Why Jellatech?
Jellatech's platform is the only solution to deliver a reliable, consistent supply of bio-identical, fully functional human type I collagen for biomedical applications. Contact us to learn more.

This is just the beginning. The potential is vast, and we’re here to help companies achieve breakthroughs in healthcare and beyond. Join us in unlocking a brighter future.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $3.5M

    Jellatech has raised a total of $3.5M of funding over 4 rounds. Their latest funding round was raised on Sep 06, 2023 in the amount of $3.5M.

  • $1M$10M

    Jellatech's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $3.5M

    Jellatech has raised a total of $3.5M of funding over 4 rounds. Their latest funding round was raised on Sep 06, 2023 in the amount of $3.5M.

  • $1M$10M

    Jellatech's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.